Bowen Therapy for Chronic Non-specific Low Back Pain
Unknown statusNot applicableNCT04861129
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
There is emerging evidence that Bowen Therapy may improve musculoskeletal pain. While it can be an effective treatment strategy to enhance pain modulation; studies on the clinical effect are scarce. The aim of this study is to examine the effectiveness of Bowen therapy for people with chronic LBP on measures of pain, function, pain-related self-efficacy, and health related quality of life. Parallel-group randomized controlled trial (RCT) study will be employed. Pain Catastrophizing Scale (PCS) will be adopted as a screening test upon the randomization. A cutoff of more than 30 points will be used to represents clinically relevant level of catastrophizing. 46 participants with informed consent who meet the eligibility criteria of study are recruited and randomly assigned to one of two groups i.e. Bowen Therapy group and Sham Bowen Conventional Therapy group. Permuted block randomization is applied to control the key confounding variable of catastrophizing which is significantly associated with pain and disability in chronic LBP. Sequentially numbered, opaque, sealed envelopes (SNOSE) is used to ensure the allocation sequence before the group allocation. Double blinding of participants and outcome assessor will be adopted. Measurements are collected at the baseline (Week 0), post-intervention (Week 6) and at a 4-week follow-up (Week 10). The primary outcomes are pain as measured by Percentage of Pain Intensity Difference (PID) and pain relief scale (PRS). The secondary outcomes are measuring the physical functioning, self-efficacy in pain and HRQoL using Owestry Disability Index (ODI), Pain Self-efficacy Questionnaire (PSEQ) and SF-12 (HK) respectively. Intervention is provided weekly for 6 sessions lasting 30-40 minutes per treatment session. The experimental group will receive Bowen therapy according to ISBT Bowen Therapy®. The control group will receive a usual OT therapy with the same number of treatment session, treatment time, including back care advice and func…
Study details
- Official title
- Bowen Therapy for Chronic Non-specific Low Back Pain: Randomized Controlled Trial
- Conditions
- Interventions
- Procedure: Bowen therapy
- Procedure: Sham Bowen therapy
- Sponsor
- The Hong Kong Polytechnic University
- Collaborators
- United Christian Hospital
- Start date
- 2021-04-19
- Primary completion
- 2021-09-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Hong Kong
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ages between 18 and 65 years * a diagnosis of low back pain with onset \> 12 weeks based on the evaluation by physician * average pain intensity score of ≥ 3 on NPRS. Exclusion Criteria: * they have acute disc prolapse or protusion with neurological sign and symptoms in the past 3-months; * bacterial spondylitis; * Rheumatoid arthritis; * ankylosing spondylitis; * back pain secondary to bone malignancy * spinal fracture; * osteoporotic collapse; * cauda equina compression * prior spinal surgery; * psychiatric disorder (e.g. psychosis / delusion); * current pregnancy * previous experience with Bowen therapy.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04861129